StageZero Life Sciences Ltd T.SZLS

RE:RE:RE:RE:Did anyone ever find out

[gojotv!]

Wow. These bashers don't have the brains to fill a thimble.

Maybe it's because guys like Liked2Poop and CackedInHisKimono don't have health coverage and never went to see a doctor.
Anyone who studied business in Kindergarten knows the importance of baking quality into a startup from the ground up. But since this simple principle is lost on our thumb-sucking bashers, let's walk them through the two scenarios... One with Care Oncology followup and one without.

In our poopy twosome's tiny minds, a person should be able to just order the test online.
"That there's  better for bidness, ain't it?" they yuk through slack jaws and rotted teeth while whittlin'.
Well, no, it isn't. That person then has to go to their doctor... in a couple of weeks if they're lucky, because the clinics are full. The doctor gets a readout of RnA indicators and other data which they weren't trained to interpret. Labs don't interpret results, doctors do. Labs just publish results. But let's say the doctor DOES get it... They then refer the patient to a specialist - another long wait - and all the while the patient gets no treatment, no emotional backup; no... shall I say it? CARE!
(Always be branding, get it?)
Meanwhile, their cancer is growing, sometimes aggressively.
This patient is already at a disadvantage, and his/her battle against cancer has been hobbled from the start.

Now, look at the Care Oncology model. The patient gets his-/her test result and is immediately given access to a professional AND a regimen of cancer-starving, inexpensive medications to begin right away, while waiting for a more profound examination, biopsies, and the structuring of a treatment plan.
This patient has had emotional and medical support from the start, vastly impacting outcomes. Their cancer was detected and battled from a very early stage, their chances of remission and even cure greatly improved.

Now, here's the billion-dollar question. Which model do you build a company on? In the highly competitive cancer-fighting market, containing everything from aromatherapy to colostomy bags, how do you get the attention and secure the trust of the bombarded-by-charlatanism medical community? Which model will, in the years to come, define treatment protocols?

The advantages of the StageZero/CareOncology model are abundantly clear.
Cheers!

Nailbiter1 wrote: The reason given for the new change of direction was because of unforeseen complications.

The large employer groups questioned what would happen if some of their people got elevated scores. Would they be satisfied with the answer "that's on you"?.
"We did our part. Thanks for buying the test and good luck with those results. Buhbye now, call again".

Now we offer full service from detection to treatment. From monitoring regression/progression of the disease to future tests to make sure the cancer remains at bay.

Second, we've seen what happened to Grail and Illumina's attempt to buy it back.

The FTC saw it as a domination play and that is no good for trading.
Squashing the competition is not favorable to the FTC.

We offer diversity. We make money, healthcare makes money, hospitals make money under the virtual direction of our new Care Oncology team. Everybody get a piece of the pie
and the Federal Trade Commission loves that and will not drag us, kicking and screaming to court.

I'm not full of $hit.

I'm 40% water, 30% vodka and only 30% $hit.

cactuseskimo wrote:

Than tell us why Nails, they made such a big deal about this fact at the launch of Aristotle - acting like it was a big revelation, which is why they needed to have their own clinic? If this was such a known fact of doing business, why did they not anticipate this problem sooner and instead wait until the last moment? And furthermore, how come people such as yourself didn't seem to mention this problem or be aware of it until after the launch of Aristotle and Care Oncology? You act like this was obvious the whole time, but no one on this board mentioned the upcoming problem prior to the release of Aristotle. You're full of $hit man.

 

Nailbiter1 wrote:

 

Liked2Think wrote: Why colonsentry and breastsentry didnt require oncologists and a program for when positives are detected but Aristotle does?

They make a big todo about saying cancer is not like covid and you need proper channels set up for cancer testing yet they never had any of that before now they suddenly need it?

Is it one specific form of cancer that makes this a criteria?
Is this the reason the previous tests didnt make money?
or is it just another load of bs?

Looks like this Care buyout is the only direction to move in for them so i guess it doesnt matter.  would be nice to know just how much we are lied to.  Shoudl we add this to the list of "fibs" or is it actually fact.

All tests have always had to be ordered from your doctor. This is not new, this has always been.
If you spent a fraction of your time actually doing some research instead of crying in public, you would know this.
Please read from our website...

If a patient receives an elevated BreastSentry score, physicians and patients may wish to proceed with informed decision making to assess whether to pursue further screening such as breast MRI, ultrasound, or digital breast tomosynthesis (DBT).

Also, you would know that even though BreastSentry shares its name with ColonSentry, it is not our test. It belongs to Germany's Sphigotec.